Abstract
The urological evaluation and results of management of 98 myelodysplastic patients are presented. Our management protocol stresses upper tract and infection status surveillance during the early childhood years, and a clean intermittent catheteriation program with pharmacological manipulation of detrusor and sphincter function as the optimal later management. Urodynamic results are valuable in treating children with difficult incontinence or poor upper tracts. The intermittent catheterization program reduces the incidence of symtomatic urinary infections in these patients, but the incidence of asymptomatic bacteriuria is high. The adverse results of supravesical diversion in myelodysplastic children rarely justify its use.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Anderson RU (1980) Prophylaxis of bacteriuria during intermittent catheterization of the acute neurogenic bladder. J Urol 123: 364–366
Blaivas JG, Labib KB, Bauer SB, Reti AB (1977) Changing concepts in the urodynamic evaluation of children. J Urol 177: 778–781
Cendron J, Schulman C (1985) Urologie pédiatrique. Flammarion, Paris
Gonzales R, Dewolf WC (1979) The artificial bladder sphinter AS-721 for the treatment of incontinence in patients with neurogenic bladder J Urol 121: 71–72
Himman F (1977) Intermittent catheterization and vesical defences. J Urol 117: 57–60
Joseph D, Bauer S (1986) Intermittent catheterization in infants with myelodysplasia. Observation and recommendation for early intervention. American Urology Association 81st annual meeting, New York (personal communication)
Kass EJ, McHugh T, Diokno AC (1979) Intermittent catheterization in children less than 6 years old. J Urol 121: 792–793
Kyker J, Gregory JG, Shah J, Schoenberg HW (1977) Comparison of intermittent catheterization in the management of children with myelomeningocele. J Urol 118: 90–91
Lapides J, Diokno AC, Silber SJ, Lowe BS (1972) Clean, intermittent self-catheterization in the treatment of urinary tract disease. J Urol 107: 458–461
Light JK, Faganel J, Roth DR, Dimitrijevic MR (1984) Meningomyelocele: a clinical, urodynamic and neurophysiological evaluation. J Urol 131: 717–719
McGuir EJ, Woodside JR, Borden TA, Wess RM (1981) Prognostic value of urodynamic testing in myelodysplastic patients. J Urol 126: 205–208
Mollard P, Klimis S, Berard J (1980) Le cathéterisme vésical intermitent pluri-quotidien. Traitement des vessies neurologique de l'enfant. Chir Pédiatr 20: 149–153
Mollard P, Mennier P, Berard J (1984) Traitement de l'incontinence urinaire d'origine neurologic chez l'enfant et l'adolescent. J Urol 90: 227–236
Perrigot M (1977) Controle neurologique de la miction. J Urol 83: 357–367
Perrigot M (1980) Pharmacologie de la vessie. Compte rendu du 3me congrés de la société internationale Francophone d'urodynamique, Rome
Plunkett JM, Bracen V (1979) Clean intermittent catheterization in children. J Urol 121: 469–471
Stone AR, Webster GD, King LR (1984) Experience with urinary tract reconstruction using intestinal segments. J Urol 131: 128–130
Webster GD, Older RA (1980) Videourodynamics. Urology 17: 106–108
Webster CD, El Mahrouky A, Stone AR, Zakrzewski C (1985) The urological evaluation and management of patients with myelodysplasia. Br J Urol 58: 261–265
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Anagnostopoulos, D., Joannides, E. & Kotsianos, K. The urological management of patients with myelodysplasia. Pediatr Surg Int 3, 347–350 (1988). https://doi.org/10.1007/BF00189174
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00189174